Valmet to Supply New Tissue Production Line to Sofidel America in Circleville, Ohio
Print this Article | Send to Colleague
Valmet will supply an Advantage DCT tissue line including an extensive automation package, flow control valves and Industrial Internet solutions to Sofidel America's Circleville mill in Ohio.
The new tissue line, which will have a design speed of 2,000 m/min and a width of 5,6 meters, will have an annual production capacity of 70,000 tons.
The new Advantage DCT 200 (TM 3) line follows the two Valmet Advantage NTT lines installed at the Circleville mill in 2017.
"Sofidel has a strong focus on sustainable and high performing technologies that can fulfill our targets to increase capacity with as low environmental footprint as possible," said Simone Capuano, Executive VP, Operations and Supply chain, Sofidel America.
Johan Björn, Sales Director, Tissue Mills Business Unit, Paper Business Line, Valmet, commented, "We are proud to continue the journey together with Sofidel. The combination of Valmet's Advantage DCT tissue machine, automation systems, flow control and Industrial Internet solutions is the most efficient production line on the market today. We will work closely together to meet the ambitious targets for the project."
Valmet's scope of supply comprises a complete tissue production line including Advantage DCT 200 tissue machine with OptiFlo headbox and Yankee cylinder. It will also be featured with the Advantage tissue technology including ViscoNip press, AirCap hood with Air system, WetDust systems and a SoftReel reel.
Valmet has also delivered detailed mill engineering, stock preparation equipment as well as automation, including Valmet DNA Distributed Control System (DCS) with built-in machine condition monitoring, Valmet IQ Quality Control System (QCS) and Web Monitoring System (WMS).
The delivery also includes Valmet's flow control and Industrial Internet solutions including Valmet Performance Center services, and Valmet Quality Predictor and Centerline Advisor applications.
